Surgical Science Sweden AB (publ) (SUSRF) Stock Price, News & Analysis

Company Overview

Surgical Science Sweden AB (publ) develops and markets virtual reality–based medical simulation solutions designed to train healthcare professionals in minimally invasive surgical techniques. Headquartered in Gothenburg, Sweden, the company leverages advanced haptic feedback and three-dimensional graphics to create realistic, interactive scenarios for a range of surgical disciplines, including laparoscopy, endoscopy and arthroscopy. Its platform allows trainees to practice complex procedures in a risk-free environment, helping to improve precision and reduce the learning curve for both trainees and experienced practitioners adapting to new technologies.

The company’s product portfolio includes LapSim for basic and advanced laparoscopic skills, EndoSim for gastrointestinal endoscopy, ArthroSim for diagnostic and therapeutic arthroscopy, as well as modules for vascular and bronchial interventions. Each simulator integrates hardware components—such as instrument handles and force-feedback devices—with software that tracks performance metrics and provides real-time feedback. Surgical Science also offers customization services for medical device manufacturers seeking to incorporate specific instruments or implantable devices into their training solutions.

Surgical Science’s customers include medical universities, teaching hospitals, professional training centers and device companies across Europe, North America and the Asia-Pacific region. Founded in 1998, the company is listed on Nasdaq Stockholm and trades in the U.S. on the OTC Markets under the ticker symbol SUSRF. Governance is overseen by a board of directors and an executive management team with expertise in simulation technology, medical device development and healthcare education.

Key Stats

• Today's Range: $4.00 to $4.00
• 50-Day Range: $2.84 to $4.09
• 52-Week Range: $3.95 to $4.09
• Volume: 15 shs
• Average Volume: 3,524 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

Company Calendar

• Today: 6/20/2026
• Next Earnings (Estimated): 8/19/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SUSRF
• CIK: N/A
• Web: surgicalscience.com
• Phone: 46317416560
• Fax: N/A
• Employees: 260
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A